Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cavitation Technologies (CVAT) Shares Outstanding (Weighted Average) (2016 - 2025)

Cavitation Technologies' Shares Outstanding (Weighted Average) history spans 16 years, with the latest figure at $295.2 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 3.83% to $295.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $295.2 million, a 3.83% increase, with the full-year FY2025 number at $286.0 million, up 0.6% from a year prior.
  • Shares Outstanding (Weighted Average) hit $295.2 million in Q4 2025 for Cavitation Technologies, up from $289.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for CVAT hit a ceiling of $295.2 million in Q4 2025 and a floor of $23.8 million in Q3 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $158.7 million across 5 years, with a median of $148.0 million in 2021.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): plummeted 89.06% in 2023 and later skyrocketed 1092.42% in 2024.
  • Tracing CVAT's Shares Outstanding (Weighted Average) over 5 years: stood at $232.7 million in 2021, then grew by 18.91% to $276.7 million in 2022, then plummeted by 89.06% to $30.3 million in 2023, then skyrocketed by 839.47% to $284.3 million in 2024, then grew by 3.83% to $295.2 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for CVAT at $295.2 million in Q4 2025, $289.2 million in Q3 2025, and $49.0 million in Q2 2025.